OGEN
Income statement / Annual
Last year (2024), Oragenics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Oragenics, Inc.'s net income was -$10.57 M.
See Oragenics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1.18 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$22.11 M
|
$62.62 K
|
$30.11 K
|
$65.80 K
|
$75.04 K
|
$481.74 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$22.11 M
|
-$62.62 K
|
-$30.11 K
|
-$65.80 K
|
-$75.04 K
|
$694.10 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0.59
|
| Research and Development Expenses |
$4.11 M
|
$15.49 M
|
$10.07 M
|
$10.59 M
|
$22.11 M
|
$12.12 M
|
$5.97 M
|
$3.54 M
|
$4.75 M
|
$8.80 M
|
| General & Administrative Expenses |
$6.44 M
|
$5.45 M
|
$4.48 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
$3.54 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.44 M
|
$5.45 M
|
$4.48 M
|
$5.27 M
|
$4.53 M
|
$3.76 M
|
$4.02 M
|
$3.18 M
|
$3.79 M
|
$3.54 M
|
| Other Expenses |
$0.00
|
-$37.65 K
|
-$131.52 K
|
-$86.99 K
|
-$22.11 M
|
$2.00 K
|
$446.00
|
-$3.10 K
|
-$4.80 K
|
-$4.70 K
|
| Operating Expenses |
$10.56 M
|
$20.90 M
|
$14.42 M
|
$15.77 M
|
$4.53 M
|
$15.88 M
|
$10.00 M
|
$6.72 M
|
$8.54 M
|
$12.35 M
|
| Cost And Expenses |
$10.56 M
|
$20.90 M
|
$14.42 M
|
$15.77 M
|
$26.64 M
|
$15.88 M
|
$10.00 M
|
$6.72 M
|
$8.54 M
|
$12.83 M
|
| Interest Income |
$45.90 K
|
$179.80 K
|
$135.90 K
|
$75.85 K
|
$89.29 K
|
$320.01 K
|
$86.53 K
|
$10.22 K
|
$40.09 K
|
$21.38 K
|
| Interest Expense |
$29.83 K
|
$0.00
|
$15.10 K
|
$15.76 K
|
$10.69 K
|
$7.30 K
|
$5.79 K
|
$216.33 K
|
$4.12 K
|
$76.67 K
|
| Depreciation & Amortization |
$0.00
|
$27.39 K
|
$44.67 K
|
$41.24 K
|
$51.71 K
|
$62.62 K
|
$30.11 K
|
$65.80 K
|
$75.04 K
|
$71.15 K
|
| EBITDA |
-$10.54 M |
-$20.60 M |
-$14.23 M |
-$15.65 M |
-$26.59 M |
-$15.50 M |
-$9.88 M |
-$6.45 M |
-$8.42 M |
-$11.56 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-9.83
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-9.91
|
| Total Other Income/Expenses Net |
-$9.10 K
|
$249.17 K
|
$132.38 K
|
$59.40 K
|
$210.76 K
|
$311.57 K
|
$80.00 K
|
-$13.21 K
|
$45.19 K
|
-$59.21 K
|
| Income Before Tax |
-$10.57 M
|
-$20.66 M
|
-$14.29 M
|
-$15.71 M
|
-$26.43 M
|
-$15.57 M
|
-$9.91 M
|
-$6.73 M
|
-$8.50 M
|
-$11.84 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-10.07
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.76 K
|
-$80.00 K
|
$13.21 K
|
$0.00
|
$59.21 K
|
| Net Income |
-$10.57 M
|
-$20.66 M
|
-$14.29 M
|
-$15.71 M
|
-$26.43 M
|
-$15.57 M
|
-$9.91 M
|
-$6.73 M
|
-$7.01 M
|
-$11.71 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-9.96
|
| EPS |
-1.6 |
-9.18 |
-7.11 |
-8.09 |
-28.05 |
-22.1 |
-45.62 |
-81.99 |
-94.35 |
-192 |
| EPS Diluted |
-1.6 |
-9.18 |
-7.11 |
-8.09 |
-28.05 |
-22.1 |
-45.62 |
-81.99 |
-94.33 |
-192 |
| Weighted Average Shares Out |
$6.62 M
|
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942.19 K
|
$704.73 K
|
$217.32 K
|
$82.10 K
|
$74.33 K
|
$61.09 K
|
| Weighted Average Shares Out Diluted |
$6.62 M
|
$2.25 M
|
$2.01 M
|
$1.88 M
|
$942.19 K
|
$704.73 K
|
$217.32 K
|
$82.10 K
|
$74.35 K
|
$61.09 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
